The gastric mucosa of mammalian stomach contains several differentiated cell types specialized for the secretion of acid, digestive enzymes, mucus, and hormones. Understanding whether each of these cell lineages is derived from a common stem cell has been a challenging problem The gastric mucosa of mammalian stomach is a dynamic epithelium in which senescent and damaged cells are continually replaced from a proliferating cell population. The gastric mucosa is specialized for the secretion of acid and digestive enzymes. Invaginations of the epithelium form gastric glands that contain several differentiated cell types (1). Surface mucous and mucous neck cells secrete mucus that serves to protect the epithelium against the acidic luminal environment. Acid-secreting parietal cells and pepsinogen-secreting chief cells are situated in the lower portions of the gastric gland. Enteroendocrine cells of the gland produce a variety of hormones including somatostatin and histamine (2). Each of these differentiated cell types appears to be derived from precursors found within a proliferative zone located at the junction of the neck and pit of each gastric gland (3, 4).
The gastric mucosa of mammalian stomach is a dynamic epithelium in which senescent and damaged cells are continually replaced from a proliferating cell population. The gastric mucosa is specialized for the secretion of acid and digestive enzymes. Invaginations of the epithelium form gastric glands that contain several differentiated cell types (1) . Surface mucous and mucous neck cells secrete mucus that serves to protect the epithelium against the acidic luminal environment. Acid-secreting parietal cells and pepsinogen-secreting chief cells are situated in the lower portions of the gastric gland. Enteroendocrine cells of the gland produce a variety of hormones including somatostatin and histamine (2) . Each of these differentiated cell types appears to be derived from precursors found within a proliferative zone located at the junction of the neck and pit of each gastric gland (3, 4) .
Whether all mature cells are derived from a common stem cell is an issue that remains to be elucidated.
Within the gastrointestinal tract, X chromosome-inactivation studies and analysis of mouse aggregation chimeras suggest that the differentiated cell types of an intestinal crypt may be derived from a common stem cell (5, 6) . Cells originating in the proliferative zone of the gastric mucosa undergo a program of terminal differentiation as they migrate toward the lumen or the base of the gastric gland. In mouse, morphologically undifferentiated granule-free cells within the proliferative zone have been identified as possible gastric mucosal stem cells (4) . However, the characterization of stomach stem cells has been limited by the lack of cell surface markers that permit precise identification of immature pre-
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cursor cell populations and the absence of cell culture systems for analyzing stem cell function.
To analyze cell lineage relationships in the gastric mucosa, we have used a genetic approach based on the thymidine kinase ablation technique (7, 8) . This method is based on the selective toxicity of the antiherpetic drug ganciclovir (GCV) to cells expressing a herpes virus thymidine kinase suicide gene. Because this ablation is conditional, the program of cell differentiation can be assessed in animals after recovery from drug treatment. We have established transgenic mice in which the promoter of the murine H,K-ATPase ,3 subunit gene was used to target expression of herpes simplex virus 1 thymidine kinase (HSV-1-tk) to parietal cells of the gastric mucosa. Treatment of transgenic mice with GCV results in parietal cell ablation, dissolution of glandular structure, and the loss of chief and mucus-producing cells. Termination of drug treatment leads to a reversal of these effects and the regeneration of gastric glands.
MATERIALS AND METHODS
Fusion Gene Construct and Production of Transgenic Mice. The parietal-cell-specific fusion gene was constructed by ligation of a 13.5-kb segment of genomic DNA (commencing at nt -29) flanking the 5' end of the murine H,K-ATPase 3subunit gene (9) to a 1.6-kb fragment of the HSV-1-tk gene. The HSV-1-tk DNA segment contains 57 bp of 5' untranslated sequence, the entire HSV-1-tk coding region, and signals for polyadenylylation (10) . Transgenic mice were generated by pronuclear injection of DNA into (C57BL6/J x SJL/J) F2 zygotes. Transgenic founders and their offspring were identified by Southern blot analysis using a 0.35-kb Bgl II-Nru I fragment of HSV-1-tk DNA (10) as probe. Transgenic lines were propagated by mating founders with CD-1 mice.
RNA Analysis. Total RNA was prepared from transgenic and wild-type mouse tissues by the guanidinium thiocyanate method of Chomczynsnki and Sacchi (11) . RNA was electrophoresed through a formaldehyde/1% agarose gel and transferred to a Zetabind (AMF Cuno) filter. Blots were probed with the 0.35-kb Bgl II-Nru I fragment of HSV-1-tk DNA. Conditions for hybridization analysis were as described (12 For immunohistochemistry, sections were dewaxed in xylene and incubated for 30 min in methanol/hydrogen peroxide. Nonspecific staining was blocked with horse serum, and the sections were incubated overnight at 4°C with primary antibodies. Slides were washed and then incubated for 30 min at room temperature in biotinylated secondary antibody (horse anti-mouse or goat anti-rabbit; Vector Laboratories). Sections were labeled with streptavidin-peroxidase (Boehringer Mannheim) for 30 min at room temperature, exposed to aminoethylcarbazole chromogen for 20 min, counterstained in hematoxylin, and mounted in Crystalmount aqueous mounting medium (Biomedia, Foster City, CA). Double immunofluorescence labeling and confocal laser microscopy were used to colocalize H,K-ATPase and tk immunoreactivity. Sections were incubated with anti-HSV-1-tk (1:100 dilution) and anti-H,K-ATPase (1:250 dilution) antibodies for 2 h at room temperature. Labeling was detected by incubation for 60 min at room temperature with Cy3-labeled donkey anti-rabbit IgG (1:300 dilution) and fluorescein isothiocyanate-labeled donkey anti-mouse IgG (1:300 dilution) (Jackson ImmunoResearch) second antibodies. Immunofluorescence was visualized by confocal laser scanning microscopy using a Molecular Dynamics confocal microscope.
RESULTS
Generation of Transgenic Mice Expressing an HKj3tk Fusion Gene. The H,K-ATPase 13 subunit promoter-HSV-1-tk (HK13tk) fusion gene was generated by linking 13.5 kb of DNA flanking the 5' end of the murine H,K-ATPase 13 subunit gene to the HSV-1-tk gene. Transgenic founder mice carrying the fusion gene were identified by PCR amplification of a diagnostic DNA fragment. Southern blot analysis of tail DNA indicated the presence of a single copy of the transgene in line 1117 (data not shown). Offspring of one female (line 1117) and one male (line 1128) founder were used for subsequent studies.
Northern blot analysis was used to examine expression of the HK13tk transgene. As shown in Fig. 1 , a 1.5-kb HSV-1-tk transcript was detected in the stomach of founder 1128. HSV-1-tk transcripts were undetectable in brain, kidney, liver, colon, and spleen. Heterozygote males from line 1117 showed an identical expression pattern (data not shown). To examine cell-specific expression of the transgene, stomach sections were double-labeled with antibodies against HSV-1-tk and H,K-ATPase. Parietal cells were stained with both HSV-1-tk ( Fig. 2A) and H,K-ATPase (Fig. 2B) antibodies. Doubleimaging (Fig. 2C) revealed that virtually all cells expressing HSV-1-tk contained H,K-ATPase, indicating that expression of the HK,Btk transgene was targeted to parietal cells.
Pathology of GCV-Treated Transgenic Mice. To ablate parietal cells, transgenic offspring from line 1117 were administered GCV for 2 weeks. Control groups consisted of transgenic mice administered isotonic saline and nontransgenic mice treated with GCV. Histological examination of the gastric mucosa of transgenic mice administered saline and nontransgenic mice treated with GCV for 2 weeks revealed a morphology identical to that of untreated normal mice. The mucosal surface and the gastric pits were lined by columnar epithelial cells (Fig. 3A) containing d-PAS-stained neutral mucin (Fig.  3B) . The epithelium in the upper third of the glands was composed predominantly of parietal cells, interspersed with mucous neck cells (Fig. 3A) . Chief cells were predominant deeper in the glands, while mitotic cells were present in the proliferative zone (neck) of the gland (Fig. 3A) . Parietal cells were immunoreactive with HSV-1-tk (Fig. 3C ) and H,KATPase (Fig. 3D) antibodies, whereas cells reactive with somatostatin antibodies were present near the base of the glands (Fig. 3E) . These results indicate that neither expression of the HK,Btk transgene nor GCV administration to normal mice causes morphological alterations in the gastric mucosa.
Marked atrophy of the stomach was apparent upon macroscopic examination of transgenic mice after 14 days of GCV treatment. However, GCV-induced injury appeared confined exclusively to the acid-secreting mucosa of stomach. No morphological changes were evident in the antrum or forestomach. Histological examination of other regions of the gastrointestinal tract, including esophagus, duodenum, jejunum, ileum, and colon, and of kidney, revealed no GCVinduced injury (data not shown). These results indicate that only the acid-secreting mucosa of transgenic mice is directly affected by the cytotoxic effects of GCV. After 14 days of GCV treatment, the entire acid-secreting mucosa appeared abnormally thin, while a layer of extremely attenuated d-PAS-negative cells covered the luminal surface (Fig. 4 A and B) . Gastric glands were devoid of recognizable parietal and chief cells. In some regions, gastric glands were markedly dilated (Fig. 4A) , whereas glands located deep in the A B C ..
.. mucosa were more compressed and lined by highly atypical and undifferentiated epithelial cells (Fig. 4B) . Elsewhere in the gastric body, no glands could be identified by standard histological criteria (Fig. 4C ). Somatostatin-containing cells were detectable ( Fig. 4E ) but were present in fewer numbers than in controls (Fig. 3E ). Large numbers of inflammatory cells were present in the lamina propria and submucosa. The acid-secreting mucosa was devoid of detectable HSV-1-tk expression (Fig. 4C) , although rare epithelial structures contained cells that were reactive with H,K-ATPase antibodies (Fig. 4D ). Whether these cells represent residual or newly differentiated parietal cells is an issue that requires further investigation. The loss of multiple stomach cell lineages by using this ablation protocol is consistent with the view that each gastric cell lineage may be derived from a common precursor cell. Recovery of GCV-Treated Transgenic Mice. Transgenic mice were treated with GCV for 14 days and then allowed to recover for 3 weeks. As shown in Fig. 5 A and (Fig. 5B) , though these were usually located in proximity to the gastric antrum. No immunostaining was detectable with either the HSV-1-tk or H,K-ATPase antibodies. However, staining of sections with a keratin antibody (Fig.  5 C and D) revealed reepithelialization over parts of the surface, with cells appearing to arise either from the gland itself (Fig. SC) or from the adjoining antrum (Fig. SD) . These results raise the possibility that epithelial cell precursors may be resident within the injured acid-secreting mucosa or may migrate into the acid-secreting mucosa from other regions of the gastrointestinal tract.
Reconstitution of the acid-secreting mucosa was complete within 20 weeks (Fig. 6) . Gastric glands displayed an apparently normal architecture and contained chief cells, mucusproducing surface and mucous neck cells, somatostatinproducing cells, and parietal cells. The reappearance of all terminally differentiated cell types after GCV removal is most consistent with the existence of a common multipotential gastric stem cell. Genetics: Canfield et aL Proc. Nati. Acad. Sci. USA 93 (1996) 2435 differentiated gastric cell types should have been observed. These results strongly suggest that all gastric cell lineages are derived from a common stem cell. Our data raise important questions regarding the site of origin of gastric stem cells that repopulate the atrophic acidsecreting mucosa. There appear to be two potential sites of epithelial cell regeneration. One is located within the corpus of the stomach, suggesting that the regenerating epithelium may arise from progenitor cells surviving within the acidsecreting mucosa. Reepithelialization also appears to originate from the antrum, raising the possibility that clonogenic cells within the antrum may be capable of migrating into the damaged mucosa and repopulating gastric glands. Within the antrum, precursor cells normally give rise to surface cells, glandular mucous cells, and enteroendocrine cells (14) . However, after migration into the damaged gastric mucosa, antral precursor cells may give rise to all differentiated gastric epithelial cells. These results suggest that environmental cues and positional information are likely to play important roles in stem cell patterning in regenerating gastric glands.
GCV is a guanosine analog that is phosphorylated by HSV-1-tk (15) . Phosphorylated GCV is believed to exert its cytotoxic effects by acting as a DNA synthesis inhibitor (7) . The primary cytotoxic action of GCV should, therefore, be directed at populations of HSV-1-tk-expressing proliferating cells. In canine stomach, Chen et al. (16) have identified a cohort of proliferating cells that express H,K-ATPase. These cells are likely to represent precursor cells committed to the parietal cell lineage. We expected that these would be the cells targeted for GCV-induced ablation in our model system. It is therefore somewhat surprising to find that mature postmitotic parietal cells are killed by GCV treatment. Since different guanosine phosphate derivatives play several key roles in cellular metabolism, it seems likely that GCV kills nonproliferating parietal cells by a mechanism other than DNA chain termination. The ablation of HSV-1-tk-expressing nonproliferative thyroid follicle cells by GCV treatment in transgenic mice (17) is consistent with this view.
An important aspect of GCV cytotoxicity in HK,Btk mice is that parietal cell ablation leads to the loss of other gastric epithelial cell lineages. However, the mechanism that leads to the loss of these terminally differentiated cell types is not clear. It is possible that proliferating H,K-ATPase expressing cells represent multipotential precursor cells. If these precursor cells express the HSV-1-tk suicide gene, GCV-induced ablation of this precursor population would be expected to result in loss of other cell lineages. Rapid loss of surface cells, which have a turnover time of 3-4 days, could occur by this mechanism. Although differentiated chief cells may be recruited from an H,K-ATPase expressing precursor cell, it is clear that mature chief cells, with a half-life estimated to be >100 days (18) , must be killed by some other mechanism. One possibility is that GCV metabolites produced in parietal cells may be cytotoxic to neighboring cells. The.disruption of glandular architecture and normal cell-cell contacts may also play a role in the loss of other gastric epithelial cell lineages. An alternative possibility is that parietal cell ablation may result in the absence of trophic factors that are essential for maintaining the viability of other epithelial cell types. The fact that parietal cells are known to produce transforming growth factor a, a potent growth factor in gastric mucosa (16, 19, 20) , is consistent with this possibility.
Parietal cell ablation in HK3tk mice raises an additional point of interest. GCV treatment results in a histopathology that bears some resemblance to chronic atrophic gastritis in humans. This disease involves an autoimmune response directed against the parietal cell H,K-ATPase (21) and is characterized by the loss of parietal and chief cells (22) . In humans, chronic atrophic gastritis often leads to the development of intestinal-type metaplasia, a pathology in which regions of normal gastric epithelium are replaced by cells that undergo an intestinal-like differentiation program (23) . Goblet cells, Paneth cells, intestinal types of endocrine cells, and tall columnar cells with prominent microvilli may all be present within the gastric mucosa. In HKf3tk mice, the regenerating acid-secreting gastric mucosa did not exhibit intestinal metaplasia. It will clearly be of interest to determine how gastric stem cells become reprogrammed to enter a differentiation program characteristic of the small intestine. The ability to target viral oncogenes to parietal cells may make it feasible to develop permanent gastric cell lines that would prove useful in this regard.
